BlinkLab develops smartphone-based digital diagnostics to assess brain developmental health, focusing on autism and ADHD. The company aims to make developmental diagnostic evaluations faster, more accessible, and more reliable through home-based assessments and clinical research collaborations. With operations spanning Australia, Europe, and the United States, BlinkLab partners with research institutions and medical centers to advance neurodevelopmental screening and diagnostic studies.
No recent news for this company.
No recent deals for this company.